Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years
- PMID: 30422794
- PMCID: PMC6240007
- DOI: 10.15288/jsad.2018.79.799
Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years
Abstract
Objective: Studies show that stimulant users have varied substance use patterns and that polysubstance use is associated with poorer past or concurrent medical, mental health, and substance use outcomes. This study examined outcomes of substance use patterns prospectively.
Method: A latent class analysis was conducted to examine substance use patterns among adults using stimulants (n = 710; 38.6% women) at baseline, and the health and treatment utilization outcomes of different use patterns over the subsequent 3 years. To examine associations between latent class membership and outcomes, generalized estimating equation modeling was conducted.
Results: Four classes of substance use patterns at baseline were identified, involving high use of (a) methamphetamine and marijuana (23%); (b) crack cocaine and alcohol (25%); (c) powder cocaine, alcohol, and marijuana (23%); and (d) nonprescribed opioids, alcohol, marijuana, crack cocaine, and powder cocaine (i.e., polysubstance [29%]). Polysubstance class members had poorer physical health and mental health status, and more severe substance use, over the subsequent 3-year period, than other class members. Regarding treatment utilization, polysubstance class members had more medical care utilization than crack cocaine class members, and more substance use treatment utilization than powder cocaine class members. The methamphetamine, crack cocaine, and powder cocaine classes did not differ from each other on any health or treatment utilization outcome.
Conclusions: People using stimulants commonly use other substances, and those whose polysubstance use includes nonprescribed opioids have especially poor health outcomes.
Figures
Similar articles
-
Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.J Subst Use Addict Treat. 2023 Mar;146:208932. doi: 10.1016/j.josat.2022.208932. Epub 2023 Jan 7. J Subst Use Addict Treat. 2023. PMID: 36880895 Free PMC article.
-
Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.Addiction. 2022 Dec;117(12):3110-3120. doi: 10.1111/add.16008. Epub 2022 Aug 5. Addiction. 2022. PMID: 35851706 Free PMC article.
-
Stimulant misuse among youth.Curr Probl Pediatr Adolesc Health Care. 2022 Sep;52(9):101265. doi: 10.1016/j.cppeds.2022.101265. Epub 2022 Sep 29. Curr Probl Pediatr Adolesc Health Care. 2022. PMID: 36184490 Free PMC article. Review.
-
Patterns of polysubstance use and simultaneous co-use in high risk young adults.Drug Alcohol Depend. 2019 Dec 1;205:107656. doi: 10.1016/j.drugalcdep.2019.107656. Epub 2019 Oct 22. Drug Alcohol Depend. 2019. PMID: 31706247 Free PMC article.
-
Drug-related decrease in neuropsychological functions of abstinent drug users.Curr Drug Abuse Rev. 2011 Mar;4(1):42-56. doi: 10.2174/1874473711104010042. Curr Drug Abuse Rev. 2011. PMID: 21466500 Review.
Cited by
-
Structural racism: a fundamental cause of drug overdose disparities.Lancet Reg Health Am. 2024 Aug 23;38:100875. doi: 10.1016/j.lana.2024.100875. eCollection 2024 Oct. Lancet Reg Health Am. 2024. PMID: 39258235 Free PMC article. No abstract available.
-
Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment.Viruses. 2024 Aug 10;16(8):1277. doi: 10.3390/v16081277. Viruses. 2024. PMID: 39205251 Free PMC article.
-
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration.J Addict Med. 2024 Sep-Oct 01;18(5):561-566. doi: 10.1097/ADM.0000000000001329. Epub 2024 Jun 3. J Addict Med. 2024. PMID: 38832683
-
Mortality, morbidity, and predictors of death among amphetamine-type stimulant users - a longitudinal, nationwide register study.Addict Behav Rep. 2024 May 14;19:100553. doi: 10.1016/j.abrep.2024.100553. eCollection 2024 Jun. Addict Behav Rep. 2024. PMID: 38800761 Free PMC article.
-
No Time to Wait: Leveraging Primary Care to Treat Stimulant Use Disorder.Am J Prev Med. 2024 Sep;67(3):464-469. doi: 10.1016/j.amepre.2024.05.005. Epub 2024 May 17. Am J Prev Med. 2024. PMID: 38762205 No abstract available.
References
-
- Baggio S., Deline S., Studer J., N’Goran A., Mohler-Kuo M., Daeppen J. B., Gmel G. Concurrent versus simultaneous use of alcohol and non-medical use of prescription drugs: Is simultaneous use worse for mental, social, and health issues? Journal of Psychoactive Drugs. 2014;46:334–339. doi:10.1080/02791072.2014.921747. - PubMed
-
- Benyamin R., Trescot A. M., Datta S., Buenaventura R., Adlaka R., Sehgal N., Vallejo R. Opioid complications and side effects. Pain Physician. 2008;11(Supplement 2):S105–S120. - PubMed
-
- Bhalla I. P., Stefanovics E. A., Rosenheck R. A. Clinical epidemiology of single versus multiple substance use disorders: Polysubstance use disorder. Medical Care. 2017;55(Supplement):S24–S32. doi:10.1097/MLR.0000000000000731. - PubMed
-
- Blonigen D. M., Bui L., Britt J. Y., Thomas K. M., Timko C. Internalizing and externalizing personality subtypes predict differences in functioning and outcomes among veterans in residential substance use disorder treatment. Psychological Assessment. 2016;28:1186–1197. doi:10.1037/pas0000250. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous

